Key Insights

Highlights

Treatment Research

1 treatments under study, led by Removal Or Leaving Of Laa Occluders

Research Leaders

20 sponsors active, led by Copenhagen University Hospital, Rigshospitalet

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 1 trials

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed with results

Key Signals

Data Visualizations

Phase Distribution

Trial Status

Unknown1

Clinical Trials (1)

Showing 1 of 1 trials
NCT05014477Unknown

Therapy Strategies After LAA Occluder Device Embolization

Showing all 1 trials

Research Network

Common Treatments

  • Removal Or Leaving Of Laa Occluders1

Active Sponsors

  • Copenhagen University Hospital, Rigshospitalet1
  • Guy's and St Thomas' NHS Foundation Trust1
  • Ibrahim Akin, Universitätsmedizin Mannheim, Germany1
  • Ignacio Amat Santos, University Clinical Hospital of Valladolid, Valladolid, Spain1
  • Jesper van der Pals, Lund University Hospital, Lund, Sweden.1

Top Investigators

  • Sophie Eppinger1

    CardioVascular Center (CVC) Frankfurt, Seckbacher Landstraße 65, 60389 Frankfurt am Main, Hesse, Germany

Related Conditions

  • Risk Factors1
  • Therapy Strategies1
  • Left Atrial Appendage Occluder1

Activity Timeline